发布求助
文献互助 智能选刊 最新文献

Medical Writing最新文献

筛选
英文 中文
AI for medical writers: Friend or foe? 医学作家的人工智能:是敌是友?
Medical Writing Pub Date : 2023-09-22 DOI: 10.56012/qovt1204
Jamie Norman, Lisa Chamberlain James
{"title":"AI for medical writers: Friend or foe?","authors":"Jamie Norman, Lisa Chamberlain James","doi":"10.56012/qovt1204","DOIUrl":"https://doi.org/10.56012/qovt1204","url":null,"abstract":"Artificial intelligence (AI) is beginning to affect almost every industry, and medical writing is no different. But how does this relate to our industry? How will AI affect medical writers? What’s already available and what is in the pipeline? Should medical writers be happy and embrace the technology, or should we resist as much as we can, assuming that we will all be replaced by machines? This article discusses the current state of the art of AI in medical writing and asks the question: AI for medical writers – friend or foe?","PeriodicalId":37384,"journal":{"name":"Medical Writing","volume":"38 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136099758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regulatory initiatives for artificial intelligence applications: Regulatory writing implications 人工智能应用的监管举措:监管写作的含义
Medical Writing Pub Date : 2023-09-22 DOI: 10.56012/kdyv1106
Anjana Bose
{"title":"Regulatory initiatives for artificial intelligence applications: Regulatory writing implications","authors":"Anjana Bose","doi":"10.56012/kdyv1106","DOIUrl":"https://doi.org/10.56012/kdyv1106","url":null,"abstract":"Applications of artificial intelligence (AI)/machine learning (ML) components in drug development are growing exponentially. The trend is expected to continue. The growth has resulted in increased engagements on the part of regulatory agencies to ensure safe and effective use. This article explores the utilisation and opportunities in three areas: medical devices (built in software applications); post-marketing surveillance (processing of large volumes of reported adverse reactions); and clinical development (pharmacokinetic profile, dose selection, clinical trial design, and regulatory writing). AI/ML-based applications are not perfect. Potential risks are enormous. Continued public/private engagement, vigilance, and oversight for all parties is essential for successful utilisation of these tools.","PeriodicalId":37384,"journal":{"name":"Medical Writing","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136099764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current clinical trial disclosure landscape in Asia 亚洲临床试验信息披露现状
Medical Writing Pub Date : 2023-09-22 DOI: 10.56012/vxbm4667
Zuo Yen Lee
{"title":"Current clinical trial disclosure landscape in Asia","authors":"Zuo Yen Lee","doi":"10.56012/vxbm4667","DOIUrl":"https://doi.org/10.56012/vxbm4667","url":null,"abstract":"The transparency and disclosure landscape in Asia has been rapidly evolving during the past decade. With respect to clinical trial registries, China launched its national registry, ChinaDrugTrials.org.cn, in 2013; South Korea introduced the new clinical trial disclosure platform through its Ministry of Food and Drug Safety (MFDS) in 2019; whilst Japan unified its three existing primary registries into a single clinical trial registry – Japan Registry of Clinical Trials (jRCT) – in 2020. We provide an overview of the national clinical trial registries and the trial results disclosure practices for 4 Asian countries – China, Japan, South Korea, and Taiwan.","PeriodicalId":37384,"journal":{"name":"Medical Writing","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136099768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Data Publication (Policy 0070) relaunch 临床数据出版(政策0070)重新启动
Medical Writing Pub Date : 2023-09-22 DOI: 10.56012/nnwx9514
Alison McIntosh
{"title":"Clinical Data Publication (Policy 0070) relaunch","authors":"Alison McIntosh","doi":"10.56012/nnwx9514","DOIUrl":"https://doi.org/10.56012/nnwx9514","url":null,"abstract":"In preparation for the relaunch of EMA Clinical Data Publication (Policy 0070), a webinar was held on May 16, 2023, and a video recording of the meeting can be viewed online (https://www.ema.europa.eu/en/events/clinical-data-publication-policy-0070-re-launch-ema-webinar). EMA Policy 0070 relaunch applies to new active substances from September 2023 onwards and includes negative and withdrawn products. Invitation letters will be sent if your product is in scope. Notably, COVID-19 and other public health emergency clinical data publication continues. EMA has confirmed that pre-submission meetings specific to a product can be offered and encourages sponsors to make use of such meetings.","PeriodicalId":37384,"journal":{"name":"Medical Writing","volume":"337 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136100501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence and Machine Learning 人工智能和机器学习
Medical Writing Pub Date : 2023-09-22 DOI: 10.56012/vrpa5453
Daniela Kamir, Shiri Diskin
{"title":"Artificial Intelligence and Machine Learning","authors":"Daniela Kamir, Shiri Diskin","doi":"10.56012/vrpa5453","DOIUrl":"https://doi.org/10.56012/vrpa5453","url":null,"abstract":"Guest Editors Daniela Kamir and Shiri Diskin provide an introduction to this issue, whose theme Artificial Intelligence and Machine Learning. We are in an era in which most people cannot imagine living without either computers or smartphones. We are well aware of how machine learning (ML) and artificial intelligence (AI) tools support our daily lives. And now, with their rapid development, medical writers can leverage these technologies to enhance productivity, quality, and innovation. The idea for a Medical Writing issue focusing on automation in medical writing arose about 2 years ago. This was quite a few months before ChatGPT became a household term, and the tool itself went swiftly into use with almost every copy-editing professional, every lawyer, and every person in any industry that uses text as their main tool of the trade. We were very interested in taking a snapshot of the landscape of tools that are currently available to medical writers and how they are being used.","PeriodicalId":37384,"journal":{"name":"Medical Writing","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136099747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Writing reports of modelling and simulation analysis: Our experience in the field of pharmacometrics 撰写模型和模拟分析报告:我们在药物计量学领域的经验
Medical Writing Pub Date : 2023-09-22 DOI: 10.56012/wmqy8556
Viviana Moroso, Mats Magnusson, E. Niclas Jonsson
{"title":"Writing reports of modelling and simulation analysis: Our experience in the field of pharmacometrics","authors":"Viviana Moroso, Mats Magnusson, E. Niclas Jonsson","doi":"10.56012/wmqy8556","DOIUrl":"https://doi.org/10.56012/wmqy8556","url":null,"abstract":"Pharmacometric analyses generate mathematical models that can describe and simulate the pharmacokinetics and pharmacodynamics of drugs. The role of these modelling and simulation (M&S) analyses is growing both in drug development and regulatory assessment. Reporting M&S analyses can be technically challenging given the large amount of input and output data that need to be summarised and accurately described in regulated reports. Therefore, reproducibility, automation, traceability, and standardisation are considered key aspects of this process. We present here a system that, using a combination of software, meets these challenges and improves the efficiency, accuracy, and reliability of our work.","PeriodicalId":37384,"journal":{"name":"Medical Writing","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136099760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systems biology and real-world data as drivers of change in drug research and development 系统生物学和现实世界的数据作为药物研究和开发变化的驱动因素
Medical Writing Pub Date : 2023-03-15 DOI: 10.56012/awvf3242
A. Sivananthan
{"title":"Systems biology and real-world data as drivers of change in drug research and development","authors":"A. Sivananthan","doi":"10.56012/awvf3242","DOIUrl":"https://doi.org/10.56012/awvf3242","url":null,"abstract":"","PeriodicalId":37384,"journal":{"name":"Medical Writing","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43849948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The unique challenges of clinical trials in rare disease: A regulatory writer’s perspective 罕见病临床试验的独特挑战：一位监管作家的视角
Medical Writing Pub Date : 2023-03-15 DOI: 10.56012/cwaa8066
S. Milner, A. Kusmierczyk, Julie Taccoen
{"title":"The unique challenges of clinical trials in rare disease: A regulatory writer’s perspective","authors":"S. Milner, A. Kusmierczyk, Julie Taccoen","doi":"10.56012/cwaa8066","DOIUrl":"https://doi.org/10.56012/cwaa8066","url":null,"abstract":"Designing clinical trials in rare diseases comes with a specific set of challenges including limited knowledge around the natural history of a disease, small sample size available for trial participation, regulatory guidance that is not calibrated to the rare disease context, manufacturing and supply issues, and safety and financial risks. Here, we discuss some of these potential challenges and how, through proactive early engagement with key opinion leaders, regulatory bodies, and patient groups, a cohesive and strategic clinical development plan can be created to provide the strongest foundations when marketing approval is sought.","PeriodicalId":37384,"journal":{"name":"Medical Writing","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44396810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Syntactic punctuation distraction 句法标点干扰
Medical Writing Pub Date : 2023-03-15 DOI: 10.56012/pbnx6491
Michael Schneir
{"title":"Syntactic punctuation distraction","authors":"Michael Schneir","doi":"10.56012/pbnx6491","DOIUrl":"https://doi.org/10.56012/pbnx6491","url":null,"abstract":"Contributors: Michael Lewis Schneir (author), Wendy Kingdom (section editor), Any Whereat (section editor)","PeriodicalId":37384,"journal":{"name":"Medical Writing","volume":"76 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135698479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overview of the European General Data Protection Regulation (GDPR) impact on medical writing for clinical trials 欧洲通用数据保护条例（GDPR）对临床试验医学写作的影响综述
Medical Writing Pub Date : 2023-03-15 DOI: 10.56012/ivhe5802
Tatiana Revenco, Gregory Collet
{"title":"Overview of the European General Data Protection Regulation (GDPR) impact on medical writing for clinical trials","authors":"Tatiana Revenco, Gregory Collet","doi":"10.56012/ivhe5802","DOIUrl":"https://doi.org/10.56012/ivhe5802","url":null,"abstract":"The European General Data Protection Regulation 2016/ 679 (GDPR) aims to ensure the security and privacy of individuals in the European Union (EU). Companies located within and outside of the EU must comply with GDPR when processing personal data of EU citizens. Medical writing includes the development of documents related to clinical research. To develop those documents, medical writers have access to personal data, including health information considered as sensitive data. Therefore, medical writing falls within the purview of GDPR and must comply with its requirements. This article is an overview of the impact of GDPR on medical writing including security measures such as anonymisation, pseudonymisation, and data minimisation techniques. It also provides an overview of the technical and organisational actions in the framework of medical writing to guarantee respect of data subjects’ rights and freedoms.","PeriodicalId":37384,"journal":{"name":"Medical Writing","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42163501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信